CSTE reported Q1 2026 results on May 13, and the story is one of structural progress colliding with a top-line that keeps shrinking.
Adjusted EPS came in at a loss of $0.32, beating the $0.35 estimate — a beat that has become Caesarstone's signature move. The EPS surprise factor score ranks in the 97th percentile, meaning the company has consistently done better than the Street expects on the bottom line. But revenue of $88.7 million missed the $97.8 million consensus by a meaningful margin. Sales fell roughly 15% year-over-year on a constant-currency basis, dragged by persistent softness in North America, a slowdown in Israel tied to regional conflict, and tariff headwinds that management flagged will hit harder in the second half. The structural story — gross margin expanding 100 basis points to 22.3% on the back of a completed shift to third-party manufacturing — is real, but it is not yet compensating for the volume loss.
The prior quarterly print, in early May, told a similar tale. The stock jumped 9.5% on that day — the March quarter was the last confirmed reaction data with a price-action marker, and that move came on positive surprise rather than revenue strength. The deeper Q4 2025 earnings history is grimmer: the company reported a net loss of $87.9 million in Q4 versus $24.3 million a year earlier, and full-year 2025 revenue dropped to $397 million from $443 million. The restructuring plan, now targeting more than $100 million in annualised savings versus 2023, is the pivot management is selling — but the market is being asked to price a recovery story while earnings capacity remains deeply negative.
Short positioning offers an interesting counterpoint to the cautious tone. Short interest has actually fallen sharply — down nearly 20% in the past week to around 1.1% of the free float, continuing a unwind that began in April when shorts roughly doubled from ~0.5% to a peak of ~1.9% before reversing hard. The borrow market reflects no urgency: cost to borrow runs at 1.5%, roughly its recent average, and availability is wide. The ORTEX short score of 30, near the bottom of its recent range, confirms that the technical short case has eased materially since late April. There is no squeeze pressure here, and no sign of fresh positioning building on the short side.
Options positioning is the clearest bullish signal in the data. The put/call ratio has dropped to 0.10, well below its 20-day average of 0.23 and near the bottom of the 52-week range — reflecting a distinct tilt toward calls over protection. That options skew is a notable contrast to the stock's 16% decline over the past month and the ongoing revenue deterioration. It points to a cohort of options participants who are positioning for a reversal rather than hedging further downside.
The ownership structure is worth noting. Kibbutz Sdot Yam holds 30% of shares, a concentration that limits the effective float and explains why the short market remains shallow despite the company's struggles. The second largest holder, Ariel Halperin, owns a further 10%, leaving institutional investors competing for a narrow slice of liquidity. Phoenix Investments recently cut its position by 2.2 million shares to 4.6% of outstanding — a meaningful reduction from a financial institution that had been a significant holder. Elsewhere, Renaissance Technologies and Millennium Management both trimmed in Q4 2025, though these are modest in scale.
Analyst coverage is thin and stale. The most recent rating action — Benchmark downgrading to Speculative Buy with a $5.00 target in March 2025 — predates the current share price of $1.32 by over a year and reflects a completely different price context. That data is not usable without significant caveat. The stock's valuation data carries similar caveats given dated reference points. The EV/EBITDA multiple of 6.9x references 2021 balance-sheet data and should not be treated as current.
The day-to-day price action tells a choppy story. CSTE gained nearly 5% on the week heading into the earnings print but fell 3.6% on May 12. Correlated peers had a rough stretch: BLDR lost 2.4% on the week and REZI dropped 9%, suggesting broad building-products weakness rather than a Caesarstone-specific dynamic. Australia remains management's bright spot — three consecutive quarters of growth there — but it represents a fraction of the revenue base. What to watch: whether the second-half tariff pressure on U.S.-bound imports, flagged clearly on the earnings call, begins to show in order trends as the quarter progresses.
See the live data behind this article on ORTEX.
Open CSTE on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
